Anlon Healthcare Ltd Q3 FY2025-26 Earnings Conference Call

Why It Matters

Anlon’s rapid revenue growth, margin stability, and capacity expansion position it to capture a larger share of the regulated API market, driving significant upside for investors and partners.

Summary

Anlon Healthcare Ltd reported a dramatic turnaround in Q3 FY26, posting total income of ₹35.78 crore versus ₹9.38 crore a year earlier and achieving an EBITDA of ₹12.54 crore at a 35% margin. The nine‑month results echoed this momentum, with revenue climbing to ₹121 crore and EBITDA reaching ₹32 crore, driven by higher API and intermediate volumes and an improved product mix.

Management highlighted a strategic push on inorganic growth, completing the acquisition of Epic Organic and moving toward a pending purchase of Exotic Life Science, which together will lift combined installed capacity to roughly 1,400‑1,600 metric tons per annum. Parallel organic expansions at the Rajkot plant and greenfield projects aim to push utilization above 90% and support a pipeline of three CDMO molecules for global innovators.

During the Q&A, executives reaffirmed the sustainability of a 35% EBITDA margin for domestic products and a 50% target for regulated markets, confirmed FY27 revenue guidance of ₹370‑380 crore, and outlined a working‑capital reduction plan to bring days‑sales‑outstanding down to 150‑160 days by FY27. They also projected positive operating cash flow by the first half of FY27, contingent on tighter payment terms and full capacity deployment.

The company’s outlook hinges on delivering a 30% compound annual revenue growth over the next three years, leveraging the expanded capacity, diversified API portfolio, and CDMO opportunities to strengthen its global footprint across 15 countries.

Original Description

Listen to 900+ live earnings calls with real-time transcript at AlphaStreet Intelligence

https://app.asai.alphastreet.io/test-drive/dashboard

Events Calendar

https://app.asai.alphastreet.io/test-drive/events

Earnings Analysis

https://app.asai.alphastreet.io/test-drive/knowledge/list

Live/On-demand Earnings Transcripts

https://app.asai.alphastreet.io/test-drive/transcript/list

Company Filings

https://app.asai.alphastreet.io/test-drive/document/list